Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Bulletin Du Cancer|April 27, 2010
[Targeted therapies: sequential and combined treatments]M Gross-Goupil, B Escudier
Bulletin Du Cancer|April 27, 2010
[Renal cell carcinoma management and therapies in 2010]B Albouy, M Gross Goupil, B Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2009
Incidence of brain metastases in renal cell carcinoma treated with sorafenibC Massard, J Zonierek, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2020
TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinomaL Albiges, P Barthélémy, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine featuresY Loriot, C Massard, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2011
Sexual life of male patients with advanced renal cancer treated with angiogenesis inhibitorsT Bessede, C Massard, B Albouy, et al.
Bulletin Du Cancer|December 22, 2009
[New drugs in metastatic castration-resistant prostate cancer]L Albiges, Y Loriot, M Gross-Goupil, et al.
Bulletin Du Cancer|December 10, 1999
[Malignant pleural mesothelioma]M Gross-Goupil, P Ruffié
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2008
The postchemotherapy PSA surge syndromeR Thuret, C Massard, M Gross-Goupil, et al.
British Journal of Cancer|March 10, 2011
Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitorsF Farace, M Gross-Goupil, E Tournay, et al.
Pageof 18